Envista Holdings (NVST) Cost of Revenue (2018 - 2026)
Envista Holdings (NVST) posted quarterly Cost of Revenue of $315.4 million for Q2 2026, up 12.28% year-over-year from $280.9 million in Q2 2025, and down 7.24% quarter-over-quarter from $340.0 million in Q4 2025.
Envista Holdings (NVST) Cost of Revenue (2018 - 2026) Analysis & Trends
Envista Holdings' Cost of Revenue history runs 9 years deep, the most recent figure standing at $315.4 million for Q2 2026.
- In Q2 2026, Cost of Revenue rose 12.28% year-over-year to $315.4 million; the TTM figure through Apr 2026 stood at $1.3 billion (up 10.06% YoY), while the FY2025 annual figure was $1.2 billion, up 8.34% from the prior year.
- Cost of Revenue for Q2 2026 stood at $315.4 million, down from $340.0 million in the prior quarter.
- The five-year high for Cost of Revenue was $340.0 million in Q4 2025, with the low at $257.3 million in Q2 2022.
- The 5-year median for Cost of Revenue is $283.7 million (2024), against an average of $288.6 million.
- The sharpest annual moves came in 2024 and 2025: Cost of Revenue retreated 9.46% in 2024, then advanced 21.26% in 2025.
- Envista Holdings' Cost of Revenue stood at $294.6 million in 2022, then grew by 5.13% to $309.7 million in 2023, then fell by 9.46% to $280.4 million in 2024, then advanced by 21.26% to $340.0 million in 2025, then decreased by 7.24% to $315.4 million in 2026.
- Business Quant data shows NVST's Cost of Revenue at $315.4 million in Q2 2026, $340.0 million in Q4 2025, and $299.7 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cost of Rev (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | 931.90 Mn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | 2.67 Bn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | 1.13 Bn |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | 602.43 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | 5.47 Bn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | 543.10 Mn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | 807.00 Mn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | 346.10 Mn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | 1.93 Bn |
| 10 | Envista Holdings | 4.40 Bn | 3.27 Bn | 407.00 Mn | 323.50 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jul 3, 2026 | 323.50 Mn |
| Jul 3, 2026 | 323.50 Mn |
| Apr 3, 2026 | 315.40 Mn |
| Apr 3, 2026 | 315.40 Mn |
| Dec 31, 2025 | 340.00 Mn |
| Dec 31, 2025 | 340.00 Mn |
| Sep 26, 2025 | 299.70 Mn |
| Sep 26, 2025 | 299.70 Mn |
| Jun 27, 2025 | 312.20 Mn |
| Jun 27, 2025 | 312.20 Mn |
| Mar 28, 2025 | 280.90 Mn |
| Mar 28, 2025 | 280.90 Mn |
| Dec 31, 2024 | 280.40 Mn |
| Dec 31, 2024 | 280.40 Mn |
| Sep 27, 2024 | 283.70 Mn |
| Sep 27, 2024 | 283.70 Mn |
| Jun 28, 2024 | 306.50 Mn |
| Jun 28, 2024 | 306.50 Mn |
| Mar 29, 2024 | 267.30 Mn |
| Mar 29, 2024 | 267.30 Mn |